McDermott Will & Emery and CK Legal advised Ryvu Therapeutics S.A., while Osborne Clarke and CMS Poland advised BioNTech on the deal. Ryvu Therapeutics S.A., a...
BioNTech’s Research Collaboration Agreement with Ryvu Therapeutics
Ryvu Therapeutics’ License Agreement with Exelixis
McDermott Will & Emery represented Ryvu Therapeutics in the transaction. Ryvu Therapeutics S.A. entered into an exclusive license agreement with Exelixis. The cooperation is focused on the...